4.5 Article

Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl-L-cysteine Synthetase (CoaB) Activity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site

Vitor Mendes et al.

Summary: Coenzyme A (CoA) is a crucial factor in various metabolic pathways and cellular processes, particularly in prokaryotes such as Mycobacterium tuberculosis. The biosynthesis of CoA involves five steps, with the second and third steps catalyzed by a bifunctional protein CoaBC in most prokaryotes. The researchers identified inhibitors of M. tuberculosis CoaB through a high-throughput screen and discovered a cryptic allosteric binding site within the enzyme.

NATURE COMMUNICATIONS (2021)

Article Chemistry, Multidisciplinary

Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth

Peter C. Ray et al.

Summary: The emergence of multi-drug-resistant strains of Mycobacterium tuberculosis has created a demand for new oral drugs with novel mechanisms of action. Several scaffolds with potential targeting of MmpL3 have been identified, but concerns remain about potential cytotoxicity and off-target effects on mammalian cells. Further research has led to the development of novel compounds with improved physicochemical properties and reduced cytotoxicity, although challenges remain in achieving effectiveness in in vivo models of tuberculosis infection.

ACS OMEGA (2021)

Article Multidisciplinary Sciences

Pyrazinamide triggers degradation of its target aspartate decarboxylase

Pooja Gopal et al.

NATURE COMMUNICATIONS (2020)

Review Immunology

Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents

Hailey S. Butman et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Letter Medicine, General & Internal

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Camus Nimmo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Microbiology

Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents

Joanna C. Evans et al.

CURRENT OPINION IN MICROBIOLOGY (2018)

Review Chemistry, Medicinal

Drug discovery in tuberculosis. New drug targets and antimycobacterial agents

Andre Campanico et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Multidisciplinary Sciences

A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK

Laurent R. Chiarelli et al.

SCIENTIFIC REPORTS (2018)

Review Chemistry, Medicinal

The Expanding Diversity of Mycobacterium tuberculosis Drug Targets

Samantha Wellington et al.

ACS INFECTIOUS DISEASES (2018)

Article Pharmacology & Pharmacy

The present state of the tuberculosis drug development pipeline

M. Daben J. Libardo et al.

CURRENT OPINION IN PHARMACOLOGY (2018)

Review Respiratory System

New drugs and perspectives for new anti-tuberculosis regimens

S. Tiberi et al.

PULMONOLOGY (2018)

Article Biochemistry & Molecular Biology

A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase

Samantha Wellington et al.

NATURE CHEMICAL BIOLOGY (2017)

Review Biochemistry & Molecular Biology

Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery

Divya Awasthi et al.

TRENDS IN MICROBIOLOGY (2017)

Article Microbiology

Longevity of major coenzymes allows minimal de novo synthesis in microorganisms

Johannes Hartl et al.

NATURE MICROBIOLOGY (2017)

Article Chemistry, Medicinal

Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis

Joanna C. Evans et al.

ACS INFECTIOUS DISEASES (2016)

Article Biochemistry & Molecular Biology

The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil

Vinayak Singh et al.

CHEMISTRY & BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Recent advances in targeting coenzyme A biosynthesis and utilization for antimicrobial drug development

Wessel J. A. Moolman et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2014)

Article Biochemistry & Molecular Biology

Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase

Zhixiang Xu et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Multidisciplinary Sciences

Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis

Madhumitha Nandakumar et al.

NATURE COMMUNICATIONS (2014)

Article Microbiology

Regulated Expression Systems for Mycobacteria and Their Applications

Dirk Schnappinger et al.

MICROBIOLOGY SPECTRUM (2014)

Article Biochemistry & Molecular Biology

Intracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress

Wonsik Lee et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis Pantothenate Kinase

Christofer Bjorkelid et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

Kevin Pethe et al.

NATURE MEDICINE (2013)

Review Biotechnology & Applied Microbiology

Advances in the development of new tuberculosis drugs and treatment regimens

Alimuddin Zumla et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Biochemistry & Molecular Biology

Crystal structures of Klebsiella pneumoniae pantothenate kinase in complex with N-substituted pantothenamides

Buren Li et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2013)

Article Biochemical Research Methods

X-ray study of the conformational changes in the molecule of phosphopantetheine adenylyltransferase from Mycobacterium tuberculosis during the catalyzed reaction

Vladimir Timofeev et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2012)

Review Biochemistry & Molecular Biology

Diverse biological activities of the vascular non-inflammatory molecules - The Vanin pantetheinases

Belinda J. Kaskow et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Article Biochemistry & Molecular Biology

The Antibiotic CJ-15,801 Is an Antimetabolite that Hijacks and Then Inhibits CoA Biosynthesis

Renier van der Westhuyzen et al.

CHEMISTRY & BIOLOGY (2012)

Article Biochemistry & Molecular Biology

Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening

Garth L. Abrahams et al.

CHEMISTRY & BIOLOGY (2012)

Article Multidisciplinary Sciences

Depletion of antibiotic targets has widely varying effects on growth

Jun-Rong Wei et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Characterization and Kinetics of Phosphopantothenoylcysteine Synthetase from Enterococcus faecalis

Jiangwei Yao et al.

BIOCHEMISTRY (2009)

Article Chemistry, Multidisciplinary

Selective Inhibitors of Bacterial Phosphopantothenoylcysteine Synthetase

James D. Patrone et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)

Review Microbiology

Coenzyme A biosynthesis: an antimicrobial drug target

Christina Spry et al.

FEMS MICROBIOLOGY REVIEWS (2008)

Article Multidisciplinary Sciences

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

K Andries et al.

SCIENCE (2005)

Article Chemistry, Medicinal

Inhibitors of phosphopantetheine adenylyltransferase

LH Zhao et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)

Article Chemistry, Multidisciplinary

Mechanistic studies on phosphopantothenoylcysteine decarboxylase

E Strauss et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)